GoodRx Holdings, Inc. (GDRX)
After hours:
| Previous Close | 6.97 |
| Open | 7.00 |
| Bid | 6.92 x 100 |
| Ask | 6.98 x 200 |
| Day's Range | 6.84 - 7.13 |
| 52 Week Range | 4.14 - 9.37 |
| Volume | |
| Avg. Volume | 1,329,146 |
| Market Cap | 2.753B |
| Beta (5Y Monthly) | 1.43 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
GoodRx Announces Date for 2024 Investor Day
SANTA MONICA, Calif., April 24, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will hold its first Investor Day on May 15, 2024, in New York City. The event will begin at 9:00 a.m. Eastern Time (6:00 a.m. Pacific Time).
- Business Wire
GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call
SANTA MONICA, Calif., April 11, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("GoodRx" or the "Company"), the leading destination for prescription savings in the U.S., today announced it will release its first quarter 2024 financial results before U.S. markets open on Thursday, May 9, 2024. GoodRx management will also hold a conference call and webcast that morning at 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) to discuss the results and the Company’s business outlook.
- Business Wire
GoodRx Interim CEO Extends Commitment to Company
SANTA MONICA, Calif., March 14, 2024--GoodRx Holdings, Inc. (Nasdaq: GDRX), the leading destination for prescription savings in the U.S., today announced Interim CEO Scott Wagner has extended his commitment to the Company. In addition, Stephen LeSieur and Adam Karol have notified GoodRx of their decision to resign from the Company’s Board of Directors, effective March 14, 2024 and March 22, 2024, respectively.
